Insights into the mechanism of azithromycin interaction with an Escherichia coli functional ribosomal complex

Molecular Pharmacology

Volumn 59, Issue 6, 2001, Pages 1441-1445

  Dinos, G P ^a   Michelinaki, M ^a   Kalpaxis, D L ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ERYTHROMYCIN; PUROMYCIN; TRANSFER RNA; TYLOSIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; INHIBITION KINETICS; ISOMERISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; RIBOSOME;

EID: 0034984901     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.6.1441     Document Type: Article

References (31)

1. Peptidyltransferase inhibitors: Structure-activity relationship analysis by chemical modification
2. Transferred nuclear Overhauser effect study of macrolide-ribosome interactions: Correlation between antibiotic activities and bound conformations
3. Conformation of macrolides antibiotics bound to ribosomes as determined from transferred nuclear Overhauser effect spectroscopy
4. Mechanism of action of spiramycin and other macrolides
5. Azithromycin and clarithromycin inhibition of 50S ribosomal subunit formation in Staphylococcus aureus cells
6. A comparison of the inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by nine different macrolide antibiotics
7. Specific inhibition of 50S ribosomal subunit formation in Staphylococcus aureus cells by 16-membered macrolide, lincosamide, and streptogramin B antibiotics
8. Action of erythromycin and virginiamycin S on polypeptide synthesis in cell-free systems
9. Ribosomal protein gene sequence changes in erythromycin resistant mutants of Escherichia coli
10. Erythromycin inhibits the assembly of the large ribosomal subunit in growing Escherichia coli cells
11. Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes
12. Interaction between the antibiotic spiramycin and a ribosomal complex active in peptide bond formation
13. Kinetic studies on the interaction between a ribosomal complex active in peptide bond formation and the macrolide antibiotics tylosin and erythromycin
14. Erythromycin binding is reduced in ribosomes with conformational alterations in the 23S rRNA peptidyl transferase loop
15. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA
16. 1-Aminocyclopropane-phosphonate: Time-dependent inactivation of 1-amino-cyclopropanecarboxylate deaminase and Bacillus stearothermophilus elanine racemase by slow dissociation behavior
17. Kinetic studies on ribosomal peptidyltransferase. The behavior of the inhibitor blasticidin S
18. Functional consequences of binding macrolides to ribosomes
19. Acid-catalyzed degradation of clarithromycin and erythromycin B: A comparative study using NMR spectroscopy
20. The behavior and significance of slow-binding enzyme inhibitors
21. The structural basis of ribosome activity in peptide bond synthesis
22. The synthesis of polyphenylalanine on ribosomes to which erythromycin is bound
23. 14C]erythromycin to Escherichia coli ribosomes
24. Antibiotic inhibition of the movement of tRNA substrates through a peptidyl transferase cavity
25. Spectrum and mode of action of azithromycin (CP-62, 993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms
26. Throwing a spanner in the works: Antibiotics and the translation apparatus
27. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in Pneumococcal strains selected in vitro by microlide passage
28. Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria
29. Erythromycin resistance by ribosome modification
30. The newer macrolides: Azithromycin and clarithromycin